|
US3311628A
(en)
*
|
1965-03-09 |
1967-03-28 |
Bristol Myers Co |
Derivatives of pyrrolo [2, 3-d] pyrimidine
|
|
CH592668A5
(ro)
*
|
1973-10-02 |
1977-10-31 |
Delalande Sa |
|
|
ES2109796T3
(es)
*
|
1994-05-03 |
1998-01-16 |
Ciba Geigy Ag |
Derivados de pirrolopirimidilo con efecto antiproliferante.
|
|
HUP0103836A3
(en)
*
|
1998-06-02 |
2003-05-28 |
Osi Pharmaceuticals Inc Uniond |
Pyrrolo[2,3d]pyrimidine compositions and their use
|
|
US6878716B1
(en)
|
1998-06-02 |
2005-04-12 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 receptor and uses thereof
|
|
US6686366B1
(en)
|
1998-06-02 |
2004-02-03 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A3 receptor and uses thereof
|
|
AU3951899A
(en)
*
|
1998-06-19 |
2000-01-05 |
Pfizer Products Inc. |
Pyrrolo(2,3-d)pyrimidine compounds
|
|
PA8474101A1
(es)
|
1998-06-19 |
2000-09-29 |
Pfizer Prod Inc |
Compuestos de pirrolo [2,3-d] pirimidina
|
|
US6680322B2
(en)
|
1999-12-02 |
2004-01-20 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 receptors and uses thereof
|
|
US6664252B2
(en)
|
1999-12-02 |
2003-12-16 |
Osi Pharmaceuticals, Inc. |
4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
|
|
US7160890B2
(en)
|
1999-12-02 |
2007-01-09 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A3 receptor and uses thereof
|
|
OA12118A
(en)
|
1999-12-10 |
2006-05-04 |
Pfizer Prod Inc |
PyrroloÄ2,3-dÜpyrimidine compounds.
|
|
US6673802B2
(en)
|
2000-12-01 |
2004-01-06 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A3 receptor and uses thereof
|
|
US6680324B2
(en)
|
2000-12-01 |
2004-01-20 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 receptors and uses thereof
|
|
DE10148883A1
(de)
*
|
2001-10-04 |
2003-04-10 |
Merck Patent Gmbh |
Pyrimidinderivate
|
|
JP2005529062A
(ja)
|
2001-11-30 |
2005-09-29 |
オーエスアイ・ファーマスーティカルズ・インコーポレーテッド |
アデノシンａ１及びａ３受容体に特異的な化合物とその使用
|
|
KR20040068317A
(ko)
|
2001-12-20 |
2004-07-30 |
오에스아이 파마슈티컬스, 인코포레이티드 |
피리미딘 ａ₂ｂ 선택성 길항 화합물, 그의 합성 방법 및용도
|
|
DE60236458D1
(de)
|
2001-12-20 |
2010-07-01 |
Osi Pharm Inc |
Pyrrolopyrimidin a2b selektive antagonistische verbindungen, deren synthese und verwendung
|
|
WO2004047843A1
(en)
|
2002-11-26 |
2004-06-10 |
Pfizer Products Inc. |
Method of treatment of transplant rejection
|
|
WO2007084667A2
(en)
*
|
2006-01-19 |
2007-07-26 |
Osi Pharmaceutical, Inc. |
Fused heterobicyclic kinase inhibitors
|
|
RS53382B
(sr)
|
2008-08-20 |
2014-10-31 |
Zoetis Llc |
Jedinjenja pirol [2,3-d]pirimidina
|
|
NL2022471B1
(en)
|
2019-01-29 |
2020-08-18 |
Vationpharma B V |
Solid state forms of oclacitinib
|
|
WO2026050970A1
(zh)
*
|
2024-09-05 |
2026-03-12 |
甫康（上海）健康科技有限责任公司 |
一种用于吡咯并[2，3-d]嘧啶衍生物的制备方法和新颖中间体
|